Skip to main content

Surgical Robots Market Size & Share Report [2021-2026] | Market worth USD 6,875.1 Mn with 21.4% CAGR

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Companies in Surgical Robots Market are Intuitive Surgical Inc., Medtronic, Stryker, Smith & Nephew, Zimmer Biomet, TransEnterix Surgical, Inc., Verb Surgical, Inc., THINK Surgical, Inc., Other Prominent Players

Pune, India, Feb. 15, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights, “Surgical Robots Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at USD 1,463.0 Mn in 2018. Fortune Business Insights predicts that the market will reach USD 6,875.1 Mn by 2026, thereby exhibiting a CAGR of 21.4% during the forecast period.

Market Growth Reasons:

  • Advantages of robotic-assisted surgery
  • Rising Regulatory Approvals Identified as Chief Growth Driver
  • Increasing penetration of surgical robots in ASCs
  • Increasing need for automation in the healthcare industry and the shifting trend towards advanced robotic surgeries


Request a Sample: https://www.fortunebusinessinsights.com/enquiry/sample/surgical-robots-market-100948


Surgical Robots Market Developments:

In January 2018, 3D Systems and Stryker had a distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for the craniomaxillofacial specialty. This partnership will drive the availability of personalized surgical planning and techniques to healthcare professionals, saving both surgeons and patients hours in the operating room.

In January 2019, Zimmer Biomet, received U.S. Food and Drug Administration clearance for the ROSA Knee System for robotically-assisted total knee replacement surgeries.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/surgical-robots-market-100948


Market Growth Factors:

As surgical robots are essentially dealing with sensitive parts of the body, regulatory authorities are somewhat reluctant to clear the products for usage. Having said that, recent advancements in surgical robots and the advent of high precision products have churned out several regulatory clearances.

Increasing regulatory approvals will favor the growth of the global surgical robots market. In 2019, Zimmer Biomet received clearance from the Food and Drug Administration (FDA) for the usage of its latest product ‘Rosa One Brain Application’.

The rise in death toll and injuries due to robotic surgeries will also impede the growth of surgical robots market. Moreover, untapped economies such as Brazil, India, China and other developing economies will create lucrative opportunities in the surgical robots market


Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/surgical-robots-market-100948


Market Segmentations:

By Application     

  • General Surgery
  • Gynecology
  • Urology
  • Orthopedics
  • Others

By End User         

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Surgical Robots Market Geographical Analysis:

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)


Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/surgical-robots-market-100948


About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.  

Contact Us:

US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.